4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-24-017373
CEO gave up 215,991 shares (to pay taxes)
- CEO acquired 390,579 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gline Matthew CEO | 2024-03-30 | Option exercise 10b5-1 | +390,579 | 1,380,642 | D: show line 1 in the form | ||
| Gline Matthew CEO | 2024-03-30 | Shares withheld for taxes 10b5-1 | −215,991 | $10.54 | $2,276,545 | 1,164,651 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Gline Matthew CEO | 2024-03-30 | Option exercise · Capped Value Appreciation Rights 10b5-1 | −994,373 | $6.40 | $6,363,987 | 0 | D: show line 3 in the form |
Loading xslF345X05/form4.xml…